Navigation Links
BioMarin to Host Third Quarter 2010 Financial Results Conference Call and Webcast on Thursday, October 28 at 5:00 p.m. ET
Date:10/7/2010

NOVATO, Calif., Oct. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, October 28, at 5:00 p.m. ET to discuss third quarter 2010 financial results.U.S. / Canada Dial-in Number:  866.202.3048International Dial-in Number:  617.213.8843Participant Code: 60493555Replay Dial-in Number: 888.286.8010Replay International Dial-in Number: 617.801.6888Replay Code: 45911037Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is curre
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMarin to Present at the Barclays Capital Global Healthcare Conference
2. BioMarins Chief Executive Jean-Jacques Bienaime to Receive Most Admired CEO Award From San Francisco Business Times
3. BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET
4. BioMarin to Present at the Morgan Stanley Healthcare Conference
5. BioMarin to Present at the Baird Healthcare Conference
6. BioMarin to Present at the Jefferies Healthcare Conference
7. BioMarin to Present at the Goldman Sachs Healthcare Conference
8. BioMarin to Present at the Deutsche Bank Health Care Conference
9. BioMarin to Present at the Baird Growth Stock Conference
10. BioMarin Announces First Quarter 2009 Financial Results
11. BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... CT (PRWEB) July 30, 2014 Connecticut ... development organization based in East Hartford, Conn., was awarded ... Phase II of a project that will determine the ... in rural north-central Connecticut. USDA Rural Development provided $53,000 ... program for the second phase of the feasibility study ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 LayerBio, Inc., ... completion of its first round of seed financing from ... enable preliminary efforts to develop a novel sustained-release product ... of our investors and their commitment to this important ... LayerBio. "Ophthalmology is one of many areas in which ...
(Date:7/29/2014)... The advanced optical methods and applications ... driving a revolution in the neurosciences were the inspiration ... by SPIE, the international society for optics and ... launch of the BRAIN Initiative in the United States, ... a vision for and provide examples of the impact ...
(Date:7/29/2014)... HOUSTON (July 29, 2014) Tough, ultralight foam ... and shape through a chemical process invented at Rice ... "GO-0.5BN" looks like a nanoscale building, with floors and ... a pair of two-dimensional materials: floors and walls of ... boron nitride platelets. , The researchers say the ...
Breaking Biology Technology:USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 2USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4Tough foam from tiny sheets 2
... Solution ... U.S. Critical Care Crisis, BALTIMORE, May 20, 2008 ICU ... at hospitals using,the eICU(R) care delivery model, according to results released ... Multimedia News Release, go to:, http://www.prnewswire.com/mnr/visicu/33159/ , Data from more ...
... AMES, Iowa, May 20 Advanced Analytical Technologies,Inc. ... newest instrument platform,the DNA PROfiler(TM) system, at BIO ... the time to identify infections which could help,clinicians ... Dr. Steven J Lasky, CEO of AATI, states, ...
... Turtle Island Soup has launched a,new ... ingredients shown to have,important health benefits, including ... The new Souper Food soups are powered ... http://www.ganedenlabs.com/ourScience.html ), a probiotic that has been,shown ...
Cached Biology Technology:Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality: 2Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality: 3Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality: 4Advanced Analytical Unveils New Instrument for Rapid Microbial Identification at BIO 2008 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 3
(Date:7/28/2014)... Food and Drug Administration (FDA) for other purposes can ... human cells, including those that cause Legionnaires, disease, brucellosis, ... mBio , the online open-access journal of the American ... non-antibiotic drugs that could one day help curb bacterial ... list inhibit the growth of at least three of ...
(Date:7/28/2014)... United States have a circulatory problem of the legs ... may even require surgery in serious cases. This disease ... turn, limb amputation. , At The University of Texas ... tested a non-surgical preventative treatment in a mouse model ... blood circulation. Their proof-of-concept study appears in the ...
(Date:7/28/2014)... that the effects of a commonly used anesthetic drug ... The study, published in this week,s issue of the ... at the University of California, San Diego and Weill ... concerns, arising from multiple studies on humans over the ... increase their susceptibility to long-term cognitive and behavioral deficits, ...
Breaking Biology News(10 mins):New route to identify drugs that can fight bacterial infections 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3
... the lineage of primates, according to scientific gospel, social ... as food, territory and reproduction. , That may well ... groundbreaking study researchers from the University of Wisconsin-Madison have ... from basic motivations to be with one another. What's ...
... damaged by ultraviolet (UV) light. , Ohio State University ... to watch strands of DNA in the laboratory sustain damage ... common chemical reaction among a family of reactions on the ... this key reaction happens with astounding speed -- in less ...
... are creating a technology that will allow doctors and ... humans and animals and watch their bones move in ... , This high-resolution, high-speed imaging system will contribute ... injuries and help scientists understand the evolution of complex ...
Cached Biology News:In young mice, gregariousness seems to reside in the genes 2In young mice, gregariousness seems to reside in the genes 3Scientists see DNA get 'sunburned' for the first time 2Scientists see DNA get 'sunburned' for the first time 3Bones in motion: Brown scientists to create new 3-D X-ray system 2Bones in motion: Brown scientists to create new 3-D X-ray system 3
Nuclear/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Polyclonal Antibody to PRG3...
Biology Products: